The Joint Commission Journal on Quality and Patient Safety is a leading publication in the field of health care quality and patient safety, under the esteemed auspices of Academic Press Inc Elsevier Science. With an impact factor reflecting its rigorous peer-review process and scholarly reputation, this journal aims to disseminate cutting-edge research, innovative practices, and effective strategies that enhance patient safety and healthcare delivery, making it an essential resource for researchers, professionals, and students alike. Operating without Open Access, the journal stands out with its impressive rankings in various Scopus categories, notably #4 in Nursing & Pediatrics and #10 in Nursing Leadership & Management, evidencing its significant impact in these fields. Since its inception in 2005, the journal has become a cornerstone for advancing knowledge and improving practices in healthcare settings, continuing to contribute to the dialogue on patient outcomes and quality improvement through 2024 and beyond. For practitioners and scholars dedicated to the advancement of healthcare standards, the Joint Commission Journal on Quality and Patient Safety remains a vital source of information and inspiration.

DRUG SAFETY is a premier academic journal published by ADIS INT LTD, dedicated to the critical field of pharmacology and toxicology. Since its inception in 1990, the journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals by providing high-quality, peer-reviewed articles that inform and advance the understanding of drug safety and efficacy. With an impressive impact factor and its current Q1 categorization in Pharmacology across various sub-disciplines, DRUG SAFETY is ranked among the top journals in its field, reflecting its commitment to excellence in scientific research. The journal features a diverse range of studies, reviews, and case reports addressing contemporary issues in drug safety, making it an invaluable tool for academia and industry alike. Although it is not an open-access journal, the content is accessible to subscribers and institutions, ensuring that essential findings in drug safety reach the widest audience possible. As the field evolves, DRUG SAFETY remains at the forefront, driving innovation and improving regulatory practices worldwide.

Pharmaceutical Medicine is a leading journal published by SPRINGER INT PUBL AG, dedicated to the field of pharmacology and pharmaceutical sciences. With ISSN 1178-2595 and E-ISSN 1179-1993, this journal serves as an essential platform for researchers and professionals to share groundbreaking findings and advancements in medication efficacy, safety, and innovative therapeutic strategies. Recognized for its contribution to the field, Pharmaceutical Medicine holds an impressive Q2 ranking in both Pharmacology and Medical Pharmacology categories, further underscored by its competitive Scopus rankings—positioned at 100/272 (63rd percentile) in Medical Pharmacology and 156/313 (50th percentile) in Pharmacology, Toxicology, and Pharmaceutics. Although it primarily operates on a traditional subscription basis, its robust academic reputation continues to attract a diverse readership worldwide. Addressed in the United Kingdom with facilities in Switzerland, the journal publishes authoritative articles from its inception in 2000 through to 2024, making it a pivotal resource for those seeking to enhance their understanding and application of pharmacological principles in clinical practice and research.

Pediatric Quality & Safety is an esteemed Open Access journal aimed at enhancing the well-being and care of pediatric patients through rigorous research and innovative practices. Published by Lippincott Williams & Wilkins since 2016, this journal provides a platform for the dissemination of critical findings in the fields of pediatrics, perinatology, and child health, boasting a respectable impact factor that places it in the Q2 category for 2023, ranking #173 out of 330 in its field. With a commitment to improving healthcare outcomes, Pediatric Quality & Safety not only offers comprehensive coverage of current research trends but also promotes best practices among healthcare professionals. It welcomes contributions from researchers, clinicians, and students alike, making it an invaluable resource for anyone dedicated to advancing pediatric care. The journal is accessible for readers worldwide, reflecting a growing emphasis on open-access knowledge and collaboration.

BRITISH JOURNAL OF HOSPITAL MEDICINE is a distinguished publication in the field of medicine, focusing primarily on the latest research, clinical practices, and advancements in hospital medicine. Published by MA HEALTHCARE LTD in the United Kingdom, this journal serves as a critical resource for healthcare professionals, researchers, and students alike, featuring insightful articles that bridge the gap between theory and practice. Holding a Q3 ranking in the miscellaneous medicine category and positioned within the top half of Scopus rankings, the journal underscores its commitment to high-quality, peer-reviewed content. With its inception dating back to 1996, the BRITISH JOURNAL OF HOSPITAL MEDICINE has evolved to include a broad spectrum of topics relevant to contemporary hospital settings, ensuring its readers are well-equipped with the knowledge necessary for improving patient care. Access options are tailored to modern readership, enhancing the visibility and dissemination of vital medical research.

The Journal of Patient Safety, published by Lippincott Williams & Wilkins, is a premier scholarly journal dedicated to advancing the field of patient safety through empirical research, innovative practices, and critical insights. Established in 2006, this journal has rapidly gained recognition, currently holding a prestigious Q1 ranking in Leadership and Management and a Q2 ranking in Public Health, Environmental and Occupational Health for 2023, reflecting its significant impact within these disciplines. With an impressive rank of #7 in Nursing Leadership and Management and #211 in Medicine Public Health as recorded in Scopus, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to improving patient safety and outcomes. The journal does not operate as an open access publication; however, its comprehensive scope and high-quality articles underscore its dedication to disseminating crucial knowledge in a field that is ever-evolving. Joining the readership of the Journal of Patient Safety means becoming part of a vital conversation aimed at redefining standards of care and enhancing safety protocols across various healthcare settings.

Safety is a prestigious Open Access journal published by MDPI, based in Switzerland, dedicated to advancing research in the fields of public health, environmental safety, and occupational health. Since its inception in 2015, the journal has become a vital resource for researchers, practitioners, and policymakers, striving to foster innovative solutions to safety challenges in various sectors. With its rigorous peer-review process and a 2023 ranking in the Q2 category for Safety Research, as well as a notable presence in public health and environmental disciplines, Safety is well-respected in academic circles, holding a Scopus rank of 37/109 in Safety Research and 87/207 in Safety, Risk, Reliability, and Quality. The journal aims to disseminate high-quality research that not only reflects the latest advancements but also aids in developing practical strategies for risk management and safety improvement. Supported by an open-access model, Safety ensures that cutting-edge research is readily available to a global audience, fostering collaboration and knowledge sharing for a safer environment.

The Turkish Journal of Anaesthesiology and Reanimation is an esteemed academic publication dedicated to advancing the fields of anesthesiology and pain medicine, as well as emergency medicine. Published by GALENOS PUBL HOUSE, this open access journal has been serving the global academic community since 2019, allowing for unrestricted dissemination of research findings and clinical practices. With its current categorization in the Q3 quartile for both anesthesiology and emergency medicine, the journal provides a valuable platform for researchers, professionals, and students alike, featuring rigorous peer-reviewed articles that enhance knowledge and inspire innovation. Located in Istanbul, Turkey, the journal actively contributes to an important dialogue in healthcare, making it a significant resource for those involved in improving patient care and outcomes. Researchers can also benefit from its increasing visibility, reflected in its Scopus rankings, positioning it within the competitive landscape of medical literature. Engage with cutting-edge research and ensure your contributions stand out in this vital field.

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.

PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.